A clinical trial to compare the effect of ondansetron in fixed dose versus according to body weight dose to prevent shivering following spinal anaesthesia for caesarean deliveries

Phase 4

• Conditions: Health Condition 1: O82- Encounter for cesarean delivery without indication

• Registration Number: CTRI/2022/09/045156
• Lead Sponsor: Dr Ananya Choudhury

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.American Society of Anaesthesiologists Physical status 2

2.Patients who have given informed and written consent

3.Patients scheduled for elective caesarean section under spinal anaesthesia

Exclusion Criteria

1.American Society of Anaesthesiologists Physical status 3 or 4

2.Patients unwilling to participate in the study

3.Preoperative use of ondansetron and tramadol

4.Presence of shivering prior to administration of spinal anaesthesia

5.Allergy or intolerance to ondansetron

6.With initial body temperature more than 38 degree celsius or less than 36.5 degree celsius

7.Presence of fetal distress or fetal abnormalities

8.Pre-existing or pregnancy induced hypertension, gestational diabetes mellitus, thyroid disorders

9.Patients with cardiac diseases, liver dysfunction and renal dysfunction

Study & Design

• Study Type: Interventional
• Study Design: Not specified